Survival and Complications of Beta-Thalassemia in Lebanon

被引:23
|
作者
Charafeddine, K.
Isma'eel, H.
Charafeddine, M.
Inati, A. [2 ,3 ]
Koussa, S. [3 ]
Naja, M.
Taher, A. [1 ,3 ]
机构
[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon
[2] Rafik Hariri Univ Hosp, Beirut, Lebanon
[3] Chron Care Ctr, Hazmieh, Lebanon
关键词
beta-Thalassemia; Lebanon; Complications; Survival;
D O I
10.1159/000171088
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
beta-Thalassemia major is a debilitating disease with a considerable incidence in Lebanon (around 2-3% carriership). The present article describes our experience to this day with 214 patients, emphasizing the survival of beta-thalassemia major and development of complications among patients with different parameters. Fifteen deaths were reported. The most common cause of death was heart failure (60%). Patients with a ferritin level of 3,000 ng/ml showed better survival than those with a level 1 3,000 ng/ml (p < 0.006). In addition, patients with a ferritin level of 1,500 ng/ml showed less complication-free survival than those with a level 1 1,500 ng/ml (p < 0.024). High level of ferritin (1,500 ng/ml) is associated with increased risk of heart failure. Overall and complication-free survival were statistically different among patients classified according to birth cohort or ferritin level. The Chronic Care Center, a multidisciplinary center located in the suburbs of Beirut, led to an increase in complication-free as well as overall survival. Although patients are being diagnosed earlier and chelation therapy is being initiated at an earlier age, complications due to iron overload still persist. The introduction of new oral iron chelators and better iron overload quantitation methods will most likely modify this picture, and a follow-up study will examine their impact. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:112 / 116
页数:5
相关论文
共 50 条
  • [21] Mutations of analysis of Beta-Thalassemia in antalya
    Kurtoglu, A. Ugur
    Aslan, V.
    Kurtoglu, E.
    FEBS JOURNAL, 2016, 283 : 180 - 180
  • [22] HEV Infection in Beta-Thalassemia Patients
    Papageorgiou, Despoina
    de Lastic, Anne-Lise
    Tsachouridou, Olga
    Metallidis, Simeon
    Akinosoglou, Karolina
    PATHOGENS, 2024, 13 (12):
  • [23] Hematuria in Patients With Beta-Thalassemia Major
    Fallahzadeh, Mohammad Hossein
    Fallahzadeh, Mohammad Kazem
    Shahriari, Mehdi
    Rastegar, Shervin
    Derakhshan, Ali
    Fallahzadeh, Mohammad Amin
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2010, 4 (02) : 133 - 136
  • [24] AN APPROACH TO PREIMPLANTATION DIAGNOSIS OF BETA-THALASSEMIA
    VARAWALLA, NY
    DOKRAS, A
    OLD, JM
    SARGENT, IL
    BARLOW, DH
    PRENATAL DIAGNOSIS, 1991, 11 (10) : 775 - 785
  • [25] BETA-THALASSEMIA AND THE PREVALENCE OF HCV VIREMIA
    SPILIOPOULOU, I
    ARVANITI, A
    KOLONITSIOU, F
    DIMITRACOPOULOS, G
    ATHANASSIADOU, A
    HAEMATOLOGIA, 1995, 27 (01) : 15 - 22
  • [26] A case of GH deficiency and beta-thalassemia
    Smacchia, M. P.
    Mercuri, V.
    Antonetti, L.
    Bassotti, G.
    D'Amico, T.
    Pietrobono, D.
    Gargiulo, P.
    MINERVA ENDOCRINOLOGICA, 2012, 37 (02) : 201 - 209
  • [27] Musculoskeletal imaging manifestations of beta-thalassemia
    Maryam Hajimoradi
    Sara Haseli
    Alireza Abadi
    Majid Chalian
    Skeletal Radiology, 2021, 50 : 1749 - 1762
  • [28] MOLECULAR CHARACTERIZATION OF BETA-THALASSEMIA IN EGYPTIANS
    HUSSEIN, IR
    TEMTAMY, SA
    ELBESHLAWY, A
    FEARON, C
    SHALABY, Z
    VASSILOPOULOS, G
    KAZAZIAN, HH
    HUMAN MUTATION, 1993, 2 (01) : 48 - 52
  • [29] SPLEEN SIZE IN BETA-THALASSEMIA HETEROZYGOTES
    TASSIOPOULOS, T
    ROMBOS, Y
    KONSTANTOPOULOS, K
    REVENAS, K
    TASSIOPOULOS, S
    AESSOPOS, A
    HAEMATOLOGIA, 1995, 26 (04) : 205 - 209
  • [30] Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach
    Saeidnia, Mohammadreza
    Shadfar, Fariba
    Sharifi, Shokoufeh
    Babashahi, Mashallah
    Ghaderi, Abolhassan
    Shokri, Mehdi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (03) : 271 - 277